CDXS codexis.com: Business Value

This price action chart for Codexis, Inc. (CDXS) demonstrates an Enterprise Value of 159.61. The business relies on synthetic biology, generating excess profits from the licensing of proprietary enzymes. Its innovative development vector is based on CodeEvolver to accelerate chemical processes in medicine. Meanwhile, the operating environment is shielded from sanctions and trade conflicts, as development is conducted strictly within the US.

Enterprise Value represents the total buyout price of a business, summing market capitalization and debt minus cash. By analyzing the market value of the business adjusted for net debt, an investor assesses the real scale of Codexis, Inc. assets during the transition to a licensing model, which allows for a more accurate forecast of the impact of lower unit costs and increased operating leverage.